15 studies found for:    Open Studies | Exclude Unknown | pancreatic disease | NIDDK
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | Exclude Unknown | pancreatic disease | NIDDK
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Condition: Cystic Fibrosis
Intervention:
2 Recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
3 Recruiting Natural History of Noncirrhotic Portal Hypertension
Conditions: Cystic Fibrosis;   Immunologic Deficiency Syndrome;   Turner Syndrome;   Congenital Hepatic Fibrosis;   Idiopathic Non-Cirrhotic Portal Hypertension
Intervention:
4 Recruiting Diagnosing and Treating Low Blood Sugar Levels
Conditions: Hypoglycemia;   Insulinoma
Intervention:
5 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
6 Recruiting Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease
Conditions: Cystic Fibrosis;   Liver Disease
Intervention:
7 Recruiting Genetic Modifiers of Cystic Fibrosis Related Diabetes
Condition: Cystic Fibrosis Related Diabetes
Intervention:
8 Recruiting Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance
Condition: Cystic Fibrosis
Intervention:
9 Recruiting BioEnergetics and Metabolomics in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
10 Recruiting Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis
Condition: Post-ERCP Pancreatitis
Interventions: Other: Indomethacin 100 mg rectally immediately after ERCP, NO prophylactic pancreatic stent placement;   Other: Indomethacin 100 mg rectally immediately after ERCP AND prophylactic pancreatic stent placement
11 Recruiting Mesenchymal Stem Cell and Islet Co-transplantation
Conditions: Chronic Pancreatitis;   Diabetes
Intervention: Biological: autologous mesenchymal stromal cell
12 Recruiting MMPPC: A Probabilistic Closed-loop Artificial Pancreas to Handle Unannounced Meals and Exercise
Condition: Type 1 Diabetes
Interventions: Device: Inpatient use of the MMPPC/DiAs system;   Device: Outpatient use of the MMPPC/DiAs system
13 Not yet recruiting Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents
Conditions: Type 1 Diabetes;   Hypoglycemia;   Hyperglycemia;   Artificial Pancreas
Intervention: Device: Hyperglycemia Minimization Algorithm
14 Recruiting Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures
Condition: Indeterminate Bile Duct Stricture
Interventions: Procedure: Multiple brushings;   Procedure: Multimodality tissue sampling
15 Recruiting Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Hypoglycemia Reduction in Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Device: Diabetes Assistant (DiAs) (Unified Safety System (USS) Virginia);   Device: Sensor-Augmented Pump Therapy (placebo)

Indicates status has not been verified in more than two years